Understand the key differences between migraine and stroke clinical trials and research opportunities
Affects ~10 million in the UK. CGRP monoclonal antibodies and gepants have revolutionised prevention and acute treatment with active trial programmes.
~100,000 strokes per year in the UK. Acute thrombectomy, secondary prevention, and rehabilitation research are key trial areas.
Migraine trials focus on quality of life and attack frequency. Stroke trials have higher stakes with acute intervention windows and mortality endpoints.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.